We are live on ! Find out more

142 hedge funds and large institutions have $640M invested in Genmab in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

18% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 45

13% more capital invested

Capital invested by funds: $564M → $640M (+$75.7M)

7.35% more ownership

Funds ownership: 36.42%43.77% (+7.4%)

7% more funds holding

Funds holding: 133142 (+9)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

99% less call options, than puts

Call options by funds: $2K | Put options by funds: $256K

Holders
142
Holders Change
+9
Holders Change %
+6.77%
% of All Funds
3.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
53
Reduced
45
Closed
18
Calls
$2K
Puts
$256K
Net Calls
-$254K
Net Calls Change
-$262K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$4.69M +$954K +42,804 +24%
Goldman Sachs
27
Goldman Sachs
New York
$4.38M +$2.37M +106,437 +106%
CS
28
Candriam SCA
Luxembourg
$4.21M +$5.35K +240 +0.1%
TIP
29
Torray Investment Partners
Maryland
$3.8M +$435K +19,507 +12%
Envestnet Asset Management
30
Envestnet Asset Management
Illinois
$3.39M +$489K +21,946 +16%
HGI
31
Hansberger Growth Investors
Wisconsin
$3.15M -$175K -7,848 -5%
Renaissance Technologies
32
Renaissance Technologies
New York
$3.15M +$3.31M +148,400 New
TCM
33
Tekla Capital Management
Massachusetts
$3.14M +$2.93M +131,628 +797%
CCB
34
Cutter & Co Brokerage
Missouri
$3.08M -$105K -4,725 -3%
Kayne Anderson Rudnick Investment Management
35
Kayne Anderson Rudnick Investment Management
California
$2.68M -$11.5K -514 -0.4%
BIM
36
Bogle Investment Management
Massachusetts
$2.65M +$839K +37,617 +43%
RJA
37
Raymond James & Associates
Florida
$2.62M +$83.1K +3,730 +3%
WJWM
38
Williams Jones Wealth Management
New York
$2.58M -$1M -44,900 -27%
Stifel Financial
39
Stifel Financial
Missouri
$2.17M +$50.1K +2,247 +2%
SF
40
Synovus Financial
Georgia
$2.1M +$61.1K +2,743 +3%
1832 Asset Management
41
1832 Asset Management
Ontario, Canada
$2.07M +$2.24M +100,400 New
Bank of New York Mellon
42
Bank of New York Mellon
New York
$1.79M -$127K -5,697 -6%
DBT
43
Dubuque Bank & Trust
Iowa
$1.53M -$181K -8,117 -10%
Skandinaviska Enskilda Banken (SEB)
44
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.49M +$1.56M +70,100 New
First Trust Advisors
45
First Trust Advisors
Illinois
$1.39M +$665K +29,854 +83%
ECM
46
ETrade Capital Management
Virginia
$1.23M +$1.29M +57,794 New
CGH
47
Crossmark Global Holdings
Texas
$1.13M +$200K +8,960 +20%
BC
48
Brinker Capital
Pennsylvania
$1.02M -$37.2K -1,670 -3%
SEI Investments
49
SEI Investments
Pennsylvania
$997K +$204K +9,166 +24%
Comerica Bank
50
Comerica Bank
Texas
$898K -$22.4K -1,004 -3%

GMAB Hedge Fund Activity: Q1 2020 in Review

142 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q1 2020, worth a combined $640M — up 13% from $564M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new GMAB positions and 18 closed out — a net gain of 11 holders — while 53 added to existing stakes and 45 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $34.3M. The largest seller was Zimmer Partners, exiting entirely with an estimated $16.7M sold.

  • 142 institutional investors held Genmab (GMAB) as of Q1 2020, up from 133 in Q4 2019.
  • Funds reported $640M of Genmab stock for Q1 2020, up 13% quarter-over-quarter.
  • 29 funds opened new Genmab positions in Q1 2020 and 18 closed out, a net change of +11 holders.
  • The largest Genmab buyer in Q1 2020 was Waddell & Reed Financial, an estimated $34.3M added.
  • The largest Genmab seller in Q1 2020 was Zimmer Partners, an estimated $16.7M sold.

Based on aggregated 13F filings for Q1 2020.